Introduction and background
Since the discovery of the fi rst antibiotic by Alexander Fleming in 1928 and its subsequent production by Florey, Chain and colleagues in 1940, 1 antibiotics have been used extensively in dentistry for the management of dental infections. Following a literature search of MEDLINE, EMBASE and the COCHRANE library (using the search criteria antibiotic and dental) covering over 5,000 references, minimal evidence-based usage of antibiotic prescribing was found for the management of acute dentoalveolar infections. Despite this, antibiotic prescribing by dentists, accounts for 7-10% of all antimicrobials prescribed throughout the community and in 1996 general dental practitioners (GDPs) were responsible for 45% of all prescriptions for metronidazole. 2, 3 In 1997 GDPs issued over 3.5 million antibiotic prescriptions. 4 Studies in the United Kingdom have consistently shown that there is widespread variation in the prescribing habits of GDPs, with many prescribing inappropriately, with inconsistent dose and frequency and often for prolonged periods. [4] [5] [6] [7] [8] [9] [10] This was also shown to be the case when patients sought advice and treatment from their general medical practitioners. 11 In a UK dental survey carried out by a major pharmaceutical company 12 looking at the factors infl uencing frequency and type of regularly prescribed antibiotic, 75% of dentists gave antibiotics at least once a week with over 15% of those dentists prescribing them on a daily basis. By far the most frequently prescribed antibiotic was amoxicillin, followed by metronidazole and almost 20% of this group of dentists prescribed both amoxicillin and metronidazole in combination. 12 A postal questionnaire by Lewis et al. 13 in 1989 showed that dental practitioners estimate that only the minority of patients (approximately 5%) had an acute infection present when they issued a prescription for antibiotics.
Microbiology
Understanding of the micro-organisms responsible for dentoalveolar infections and their susceptibility to various antibiotic agents has progressed signifi cantly In addition, increasing resistance to antibiotics has led to the need for more appropriate prescribing and to review whether prescribing antibiotics is required at all.
Improved microbiological sampling techniques and better transport media have aided more accurate assessment of the bacteria involved in specifi c dentoalveolar infections and led to more appropriate antibiotic usage. Culture and sensitivity methods still take time and often antibiotics are prescribed empirically prior to sensitivity results being available, although the choice of antibiotic may be based on previously cultured bacteria and their sensitivities. However the continued development of molecular microbiological techniques, which can provide rapid detection of penicillin resistance in pus, will aid with more accurate prescribing in future.
• Provides an overview of appropriate prescribing of antibiotics in the management of the adult patient with a dentoalveolar abscess.
Most dentoalveolar infections arise from overgrowth of normal commensals within the oral cavity as a result of changes in local environmental conditions, leading to opportunistic infections.
14 Once bacterial growth exceeds the minimum infective dose, a dentoalveolar infection may arise. Dentoalveolar infections are not caused by a single micro-organism but are mixed infections and there is progression of the microbial species as the infection develops refl ecting ecological changes in the affected site. [14] [15] [16] It is widely accepted that dentoalveolar infections affecting the periapical tissues are predominantly comprised of strictly anaerobic Gram-positive cocci and Gramnegative rods mixed with facultative anaerobic fl ora. 14, 15, 17, 18 The predominance of anaerobic micro-organisms within these infections has previously been underestimated. This is in part due to poor sampling techniques and transport media and in addition to inadequate culture media and failure to use prolonged periods of anaerobic incubation. 19 In mixed infections, strictly anaerobic species exceed facultative anaerobic species by 3-4 times 14, 15, [17] [18] [19] [20] [21] [22] and strict anaerobes usually account for the greater percentage of overall viable bacteria within the mixed abscess fl ora. 21 In dentoalveolar infections related to the periodontium eg pericoronitis, acute necrotising ulcerative gingivitis (ANUG) and lateral periodontal abscesses, the predominant organisms are obligate anaerobes derived from the normal commensals of the periodontal tissues. 14, 15, 17, [23] [24] [25] [26] [27] [28] 
Current prescribing practices
Prescribing of antibiotics for the treatment of dentoalveolar abscesses is usually empirical with wide variation in prescribing habits amongst general dental and general medical practitioners. [4] [5] [6] [7] [8] [9] [10] [11] The defi nitive treatment of a dentoalveolar abscess is drainage and removal of the cause of the infection. 14, 17, 18, [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] In the majority of cases this is the only treatment required. However if the patient is showing signs of systemic illness as a result of their dentoalveolar infection, or are signifi cantly immunocompromised, then adjunctive therapy with antibiotics may be indicated.
An abscess is a localised collection of bacteria, infl ammatory cells and tissue breakdown products. Extracellular enzymes derived from the bacteria, or the host, within the abscess have tissuedamaging potential.
14 The host response is to allow drainage of pus by the path of least resistance. Dependent on the anatomical position of the abscess, pus may drain through adjacent soft tissues, via the periodontal ligament, via the tooth or may take a deeper course through tissue or fascial spaces. Spread of pus around the muscles of mastication leads to a reduction in inter-incisal opening and presents clinically as trismus. Trismus must therefore be regarded as a signifi cant indicator of severe odontogenic infection. 40 In addition bacterial metabolites, along with endotoxins and exotoxins, may enter the blood stream. These affect the thermoregulatory centre in the hypothalamus leading to an increased body temperature, seen clinically as pyrexia. 14 Left untreated the bacteria in the bloodstream may reproduce resulting in septicaemia causing a systemic infl ammatory response, leukocytosis and potential end organ damage; this may be fatal. The Offi ce for National Statistics for [2000] [2001] [2002] [2003] [2004] [2005] report that between 8-16 patients died per year in England and Wales from dentoalveolar abscesses. 41 Antibiotic treatment is essential to treat septicaemia by killing dividing bacteria in the blood stream. Clinical signs of pyrexia, trismus, signifi cant regional lymphadenopathy, gross facial swelling, closure of the eye, dysphagia, tachycardia and rigors should be regarded as indicators of systemic response to infection and adjunctive antibiotic therapy is always indicated. 7, [14] [15] [16] 29, [31] [32] [33] [34] [35] [37] [38] 40, 42, 43 Where there is systemic involvement treatment involves drainage of the abscess primarily to allow the release of pus, reduce the overall number of microorganisms, decrease the tissue pH, increase oxygen diffusion and allow antibiotics to penetrate.
14 This is followed by removal of the cause of the infection and adjunctive antibiotic therapy. Drainage can be achieved either by removal of necrotic pulp, extraction of the tooth or incision of the soft tissues overlying the abscess.
For the antibiotic to be successful in overcoming the associated systemic symptoms, it must be active against the micro-organisms present, be sensitive to those bacteria and be given in adequate dose, frequency and duration to aid resolution of the systemic symptoms. The minimum inhibitory concentration (MIC) is the least amount of antibiotic required to inhibit further growth of the responsible micro-organisms. The blood concentration should exceed this MIC by a factor of four times to allow the antibiotic to penetrate the tissue in suffi cient concentration to kill or inhibit further growth of the infecting microorganism. 14, 16, 44 Historically antibiotics have been prescribed in courses for between 5-10 days duration and the patient has been instructed to complete the course. It is now becoming increasingly evident that long courses of antibiotics are not required and indeed may destroy the homeostasis of the oral micro-fl ora and lead to colonisation resistance. 14 In addition, long courses of antibiotics may increase the selection of resistant micro-organisms and resistance plasmid transfer by conjugation.
14 Antibiotics are prescribed with the intention of eradicating microbial systemic involvement and can be discontinued safely after resolution of these signs. Usually they can be discontinued after 2-3 days. 14, 16, [31] [32] [33] Resistance Within the oral cavity there is a complex ecosystem of micro-organisms which is continually changing and diversifying in response to local conditions. This is a relatively stable community and resists colonisation by other micro-organisms leading to colonisation resistance. 45 The importance of the role of these normal micro-fl ora in preventing disease is becoming increasingly realised. 2, 14, 17 The homeostasis of the normal oral fl ora can be disrupted by antimicrobial agents which may interfere with adherence, or kill normal commensals, allowing for major changes in the microbial community enabling overgrowth of resistant organisms. This is the basis by which pseudomembranous colitis (PMC) develops in the colonic microfl ora. Disturbance to the normal colonic micro-fl ora may allow for selection and overgrowth of Clostridium diffi cile leading to the production of toxins and the development of PMC. 45 Following the advances in the 1940s and 1950s in antibiotic therapies the outlook for the control of infectious diseases was good. The adaptability and potential for survival of the micro-organisms was underestimated until bacterial strains were found to be evading antibiotic therapies by selection of resistant strains. This has now progressed to such an extent that certain antimicrobial agents have been rendered useless in the treatment of specifi c infections. 46 Such is the case with the emergence of methicillin resistant Staphylococcus aureus (MRSA), vancomycin resistant Staphylococcus aureus (VRSA), multiple drug resistant Mycobacterium tuberculosis and vancomycin resistant Enterococci. [46] [47] [48] Such resistant bacteria can spread from patient to patient causing further problems with resistance and treatment. This has now become an international problem and is one of great and increasing concern.
1,2,47-56 It is clear that the widespread and often indiscriminate use of antibiotics, generally prescribed on an empirical rather than a rational basis, has led to increasing numbers of resistant bacteria. It is therefore essential that this situation is fi rstly recognised and secondly that radical changes in prescribing habits are made to reduce the rate at which new resistance accumulates. 2 
Antibiotics in agriculture
Resistance has also been exacerbated by the widespread use of antibiotics used in animal agriculture and farming to promote growth of the animals and prevent disease spread amongst crops. Following the Swann Report in 1969, restrictions on antibiotic use in these industries were made in the UK, but widespread usage continued in other countries. In addition, antibiotics prescribed by veterinary surgeons have resulted in enteric bacteria resistant to the veterinary antibiotic apramicin showing cross-resistance to gentamicin. This led to the Lamming Report in 1992 recommending that veterinary use of antimicrobial agents showing this cross-resistance to agents used in human medicine should be 'discouraged'.
2,34,50

Resistance changes
In 1946, six years after the introduction and production of penicillin, it was found that approximately 90% of Staphylococcus aureus isolates were sensitive to penicillin. By 1952 this had decreased to 75% and by 1998 to approximately only 5% being sensitive. 34, 48, 52 Penicillin resistant bacteria are often present in the micro-fl ora of acute dental infections. [53] [54] [55] Eick et al. 57 showed that the majority of micro-organisms isolated from pus from dento-alveolar abscesses were Gram negative anaerobes and were highly susceptible to metronidazole and clindamycin, but that 22% of isolated bacteria produced beta-lactamases and were resistant to penicillin.
Last year data published by Kuriyama et al. 58 showed that 34% of micro-fl ora from odontogenic abscesses were resistant to the penicillin group of antimicrobials demonstrating a rising trend in the levels of resistant organisms involved in dentoalveolar infections and questioning the ongoing suitability of penicillins as the fi rst line treatment for such infections.
In a randomised operator-blind comparative clinical trial, testing the efficacy of co-amoxiclav with penicillin V for dentoalveolar infections, after drainage all improved but patients on coamoxiclav reported signifi cantly greater decrease in pain during the second and third days post drainage. This may be related to the eradication of the betalactamase producers with co-amoxiclav that would not be eradicated by penicillin V. 54 All of these data support the contention that phenoxymethylpenicillin should not be the fi rst choice of antibiotic for dentoalveolar infections.
Clindamycin
The spectrum of activity of clindamycin covers a range of micro-organisms and most of those found in acute dentoalveolar infections, including those that are showing resistance to the penicillins. 18, 20, 53, [59] [60] [61] In addition, clindamycin is well absorbed orally and has a superior bone penetration when compared with other antimicrobials that have a similar spectrum of activity. 60, [62] [63] [64] It also has stimulatory effects on the immune system. 59 All these factors suggest it could be a highly appropriate choice for managing the systemic involvement associated with acute dentoalveolar abscesses.
Unfortunately clindamycin has long been associated with causing acute pseudomembranous colitis in patients, which can have fatal consequences. It has therefore not been used as a fi rst line choice of antibiotic for odontogenic abscesses. Its use, however, is now increasing and it has been suggested that this could be the antibiotic of choice for adjunctive management of acute dentoalveolar abscesses. 15, 18, 40, 59, 63, 65, 66 For the past 15 years it has been used as a penicillin alternative for antibiotic prophylaxis for the prevention of bacterial endocarditis in patients either allergic to penicillin or those who have had a recent course of penicillin, 67, 68 highlighting its spectrum of activity in combating the relevant oral fl ora. PMC can be caused by an overgrowth of Clostridium diffi cile, which is found in the colon as a normal commensal in approximately 2-3% of healthy adults. This carriage rate increases in the elderly, patients with a history of gastrointestinal disease, the chronically ill, patients on long term antibiotic therapy and those who have been hospitalised. [69] [70] [71] [72] [73] [74] Overgrowth of Clostridium diffi cile following antimicrobial therapy may cause complications ranging from simple watery diarrhoea, which may resolve on discontinuation of the antimicrobial, to PMC which can result in fever, abdominal pain, severe dehydration and death. [69] [70] [71] Toxic megacolon and acute peritonitis following perforation of the colon are the most serious complications. 74 The association of PMC with the use of clindamycin understandably added to the risk of choosing this as a fi rst line antibiotic. However, more recent studies have shown that the chance of developing PMC with the use of clindamycin is no higher than other antimicrobials including amoxicillin 18, 48, 59, 60, 69, 75 and in fact is lower than the risk for using co-amoxiclav, 59 with an overall incidence of causing PMC of less than 1%. 66 The risk of developing PMC significantly increases if clindamycin is used in conjunction with other antibiotics and one study shows that the risk more than doubles when used in conjunction with ampicillin. 76 If clindamycin is used, patients should be warned that if they do develop gastrointestinal symptoms/diarrhoea, they should stop their antimicrobial therapy and contact the person who prescribed it for further investigation. Considering that normal colonisation with Clostridium diffi cile increases with age, illness and a history of gastrointestinal disease, caution would be advised when prescribing clindamycin to this group of patients. 60 Similarly those patients who have recently been in-patients in hospital or who have been on long term antibiotic therapy may be more likely to develop PMC and this may infl uence the choice of antimicrobial prescribed. 60 There have been reports of resistance to clindamycin emerging in community acquired MRSA, although the prevalence seems to be low. As Staphylococcus aureus is rarely implicated in dentoalveolar abscesses, for the time being, clindamycin should still be considered in the management of acute dentoalveolar abscesses with signs of systemic illness.
77,78
Recommendations
In the current climate of evidence-based medicine an attempt has been made to rationalise the use of antibiotic prescribing for adult patients attending with acute dentoalveolar infections. Most can be successfully treated with surgical drainage followed by removal of the cause of the infection. For those patients who have become systemically unwell as a result of their infection, or those who are signifi cantly immunocompromised, the same principles are followed along with adjunctive antibiotic therapy to manage their systemic involvement.
Infections derived from the periodontal tissues are anaerobic in nature and metronidazole is the antimicrobial of choice. 79 Infections derived from periapical tissues are mixed infections, but predominantly anaerobic, and are most appropriately treated with amoxicillin, metronidazole or clindamycin (Fig. 1) .
A number of studies have shown that patients respond well when treated with amoxicillin 36, 49, [52] [53] [54] 57 despite the evidence of resistant strains and Ingham et al. 80 found that metronidazole was as benefi cial as penicillin, surmising that this indicated that the anaerobic population of bacteria were most pathogenic. However it may be that effective drainage to reduce the number of bacteria, promote aerobic conditions and optimise a return to health may be the most important part of the process of abscess resolution.
The increasing levels of resistance to penicillin and the emerging interest and usage of clindamycin may make clindamycin a more appropriate choice of antimicrobial in those patients who are at low risk of developing PMC. This has already been advocated by Sandor et al. 20 As antibiotics are prescribed with a view to preventing bacterial multiplication in the blood stream they can be safely discontinued once the systemic signs of infection are eradicated. Following effective drainage, these signs usually resolve within 2-3 days of antibiotic usage and therefore the antibiotic treatment can be stopped at this stage.
With regards to dosage the lowest possible effective dose should be used. In order to achieve suffi cient concentration of antibiotic in the tissues, the blood concentration should exceed the MIC by a factor of four. A dose of 250 mg amoxicillin three times daily, 200 mg metronidazole three times daily or a dose of 150 mg clindamycin four times daily will be suffi cient to achieve the required blood concentration.
The primary treatment for managing acute dentoalveolar infections is to provide drainage.
Antibiotics may be used as an adjunct when treating patients showing signs of systemic involvement.
Systemic involvement signs:
Elevated body temperature >36.8˚ C Gross swelling
Trismus
Regional lymphadenopathy
Tachycardia
Immunocompromised patients may require more radical use of antibiotics.
The ratio of risk: benefit must be considered on an individual patient basis. Given the annual costs to the National Health Service involved in prescribing antibiotics, the increasing levels of bacterial resistance, the emergence of bacterial strains resistant to multiple antimicrobial agents and the never ending increase in litigation, care should be taken when prescribing antibiotics for acute dentoalveolar infections associated with systemic illness and emphasis should be placed on the provision of adequate drainage and rational prescribing.
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